Dare Bioscience, Inc. ( DARE) - Key Metrics
DARE Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.20 | -$0.46 | -$0.46 |
| 2026Q1 | $0.01 | -$0.21 | -$0.38 | -$0.38 |
| 2025Q4 | $0.07 | -$0.10 | $0.10 | $0.09 |
| 2025Q3 | $0 | -$0.28 | -$0.03 | -$0.05 |
| 2025Q2 | $0 | -$0.45 | -$0.61 | -$0.59 |
DARE Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -2.64 |
| 2026Q1 | 0% | -2.17 |
| 2025Q4 | 0% | -4.85 |
| 2025Q3 | 0% | -1.88 |
| 2025Q2 | 0% | -1.33 |
DARE
Price: $0.74
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.62 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 165200
Ebitda: -1.3 millionMarket Capitalization: 12.6 million